Investor Presentaiton slide image

Investor Presentaiton

20 Financial Snapshot Q3 2020 Revenue: $8.8 MM Significant Glaucoma Growth Shifting Revenue Mix Revenue Breakdown at 9/26/20 O.U.S 40% Systems 41% U.S. 60% Recurring 59% 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 2015 2016 2017 2018 2019 Q1 Q2 Q3 2020 2020 2020 Cash PPP Loan Retina Other Glaucoma Balance Sheet at 9/26/20 ($ in millions) $11.9 $2.5 IRIDEX
View entire presentation